Morris Gabriel S
SEC insider (Form 3/4/5 filer). CIK 0001889967. CFO, President at Immix Biopharma, Inc. (IMMX). 6 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in LOS ANGELES, CA.
Companies Morris Gabriel S has filed insider reports for
- Immix Biopharma, Inc. (IMMX): Director, Officer, CFO, President
Morris Gabriel S
CIK: 0001889967
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Immix Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 22, 2026IMMX
Immix Biopharma, Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - Dec 10, 2025IMMX
Immix Biopharma, Inc.
PurchaseDirect770 shares at avg. $6.58$5K - Dec 8, 2025IMMX
Immix Biopharma, Inc.
In-the-MoneyIndirect156K shares at avg. $0.80$125K - Sep 16, 2025IMMX
Immix Biopharma, Inc.
PurchaseDirect2.6K shares at avg. $1.97$5K - Jun 20, 2025IMMX
Immix Biopharma, Inc.
AwardDirectStock Option (Right to Buy)
340K shares- - Jun 18, 2025IMMX
Immix Biopharma, Inc.
PurchaseDirect2.2K shares at avg. $2.28$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Dec 10, 2025 | IMMX Immix Biopharma, Inc. | Purchase | 770 | $6.58 | $5,067 | Direct |
| Dec 8, 2025 | IMMX Immix Biopharma, Inc. | In-the-Money | 156,000 | $0.80 | $124,800 | Indirect |
| Sep 16, 2025 | IMMX Immix Biopharma, Inc. | Purchase | 2,600 | $1.97 | $5,122 | Direct |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | Award Stock Option (Right to Buy) | 340,000 | - | - | Direct |
| Jun 18, 2025 | IMMX Immix Biopharma, Inc. | Purchase | 2,225 | $2.28 | $5,071 | Direct |
1-6 of 6 transactions